BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
MYC
,
glucose metabolic process
,
Hepatitis
,
Intestine
,
Amniocentesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
protein phosphatase inhibitor
Summary
General Info
Curated Studies
Most Correlated Studies
Breast adenocarcinoma cells treated with nutlin-3a or/and Wip1 inhibitor GSK2830371
Cerebellar neuron precursors treated with SSH, cyclohexamide and growth arrest conditions
Multiple myeloma RPMI8226 cells treated with eIF2a phosphatase inhibitors, Guanabenz and Sal003
Shiga toxin-induced gene expression in THP-1 monocytic leukemia cells
Wildtype yeast response to calcineurin inhibitor, Ca2+ or Na+
Explore Curated Studies Results
Literature
Most Relevant Literature
Exploiting protein phosphatase inhibitors based on cantharidin analogues for cancer drug discovery.
Mechanism of activation of PKB/Akt by the protein phosphatase inhibitor Calyculin A.
Protein tyrosine phosphatase inhibitors: a patent review (2002 - 2011).
Synthesis of optically pure norcantharidin analogue NCA-01, a highly selective protein phosphatase 2…
Comparative toxicological study of the novel protein phosphatase inhibitor 19-Epi-okadaic acid in pr…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma
Is T-lymphocyte Calcineurin Phosphatase Up-regulated by Treatment With Tacrolimus?
Tumor Kinase Inhibitor Concentrations Measured by PET
Study of Akt Inhibitor MK2206 in Patients With Relapsed Lymphoma
Regorafenib Combined With PD-1 Inhibitor Therapy for Second-line Treatment of Hepatocellular Carcino…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ